InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures ...

In the investment presentation below, we detail our investment outlook for InMode. InMode-Pitch-deckDownload.

Events & Presentations, Upcoming Events, Coming Soon, Past Events, Event, Barclays Global Healthcare Conference, 17 Marzo, 2022, Axtarishcast, Event Details.

Corporate Video · Press Releases · Financials · Events · Shareholders · Stock Quote · Analyst Coverage · IR CONTACT · Investor FAQ · CSR ...

1 авг. 2024 г. · InMode reported GAAP net income of $23.8 million, or $0.28 per diluted share, in the second quarter of 2024, compared to $55.7 million, or $0.65 ...

InMode's 2020 products like Morpheus8 and Evoke have outperformed initial expectations. Their co-founders, Moshe Mizrahy and Dr Michael Kerindel, previously ...

2 мая 2024 г. · Company Announces Share Repurchase Program of Up to 8.37 Million Shares; and. Appoints New Chairman of the Board of Directors.

InMode offers innovative medical devices for minimally invasive and non-invasive cosmetic treatments providing superior results for face, body, ... About InMode · Treatments · IgniteRF · OptimasMAX

1 авг. 2024 г. · Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode.